Isotope-coded affinity tag reagents and high throughput mass spectrometry were used to quantitate changes in the expression of 150 proteins in mouse wild-type (p53 ؉/؉ ) cortical neurons undergoing DNA damage-induced death. Immunological techniques confirmed several of the changes in protein expression, but microarray analysis indicated that many of these changes were not accompanied by altered mRNA expression. Proteome analysis revealed perturbations in mitochondrial function, free radical production, and neuritogenesis that were not observed in p53-deficient neurons. Changes in Tau, cofilin, and other proteins recapitulated abnormalities observed in neurodegenerative states in vivo. Additionally, DNA damage caused a p53-dependent decrease in expression of members of the protein kinase A (PKA) signaling pathway. PKA inhibition promoted death in the absence of DNA damage, revealing a novel mechanism by which endogenous down-regulation of PKA signaling may contribute to p53-dependent neuronal death. These data demonstrate the power of high throughput mass spectrometry for quantitative analysis of the neuronal proteome.
Isotope-coded affinity tag reagents and high throughput mass spectrometry were used to quantitate changes in the expression of 150 proteins in mouse wild-type (p53 ؉/؉ ) cortical neurons undergoing DNA damage-induced death. Immunological techniques confirmed several of the changes in protein expression, but microarray analysis indicated that many of these changes were not accompanied by altered mRNA expression. Proteome analysis revealed perturbations in mitochondrial function, free radical production, and neuritogenesis that were not observed in p53-deficient neurons. Changes in Tau, cofilin, and other proteins recapitulated abnormalities observed in neurodegenerative states in vivo. Additionally, DNA damage caused a p53-dependent decrease in expression of members of the protein kinase A (PKA) signaling pathway. PKA inhibition promoted death in the absence of DNA damage, revealing a novel mechanism by which endogenous down-regulation of PKA signaling may contribute to p53-dependent neuronal death. These data demonstrate the power of high throughput mass spectrometry for quantitative analysis of the neuronal proteome.
Recent reports indicate that it is not always possible to reliably extrapolate from changes in mRNA expression levels to changes in protein expression (1) . Although cDNA microarray technology provides a comprehensive, high throughput tool for characterizing changes in mRNA expression, methods for the broad analysis of changes in protein expression on a scale similar to that obtained with mRNA analyses have not previously been available. Because variations in protein expression and function are the primary determinants of cellular behavior, however, the ability to quantitatively measure changes in the expression of a large number of proteins within a given cell or tissue is needed.
Until recently, most proteome analyses have been performed using two-dimensional PAGE, followed by mass spectrometric identification of the visualized proteins. The utility of this approach, however, is limited by several factors, including the labor-intensive nature of the technique, its low sensitivity, and a significant bias against proteins with extreme molecular weights or isoelectric points (2) . Fortunately, recently developed methods such as stable isotope labeling and multidimensional fractionation coupled directly on-line with mass spectrometry (MS) obviate the need for two-dimensional PAGE. These methods promise to increase the speed, dynamic range, and sensitivity of protein identification and quantitation. In this study, isotope-coded affinity tag (ICAT) 1 reagents were used in combination with ion trap (IT) and Fourier transform ion cyclotron resonance (FTICR) MS to study p53-dependent cell death processes that occur in primary mouse cortical neurons after DNA damage (3, 4) .
The p53 protein can act as either a site-specific transactivator or a repressor of transcription and can promote apoptosis by modulating the expression of select genes (5) . The absence of the p53 gene has been shown to protect neurons from damage caused by ionizing radiation, chemotherapeutic agents, excitotoxins, and hypoxia (5) . Moreover, overexpression of p53 using adenovirus-mediated gene transfer induces neuronal death (6, 7) . Other studies have implicated p53 in the pathogenesis of neurodegenerative diseases including Huntington's disease and Alzheimer's disease (5) .
Previous studies in our laboratory and others have implicated proapoptotic proteins such as Bax (3), caspases (4), Peg3/ Pw1 (8), APAF-1 (9), (10) and cyclin-dependent kinases (11) in neuronal death pathways activated by p53. Despite these insights, however, the downstream molecular consequences of p53 activation in neurons remain obscure. Thus, a more comprehensive approach to the investigation of p53-dependent neuronal death pathways is needed. We report here the use of mass spectrometry and differential isotope labeling to quantitate simultaneous changes in the expression of hundreds of neuronal proteins after DNA damage induced by exposure to the topoisomerase I inhibitor, camptothecin. The mass spectrometry results were validated using immunoblotting tech-niques and compared with cDNA array analysis of the same cell systems. The data reveal p53-dependent regulation of multiple processes that either promote or reduce neuronal viability after DNA damage.
EXPERIMENTAL PROCEDURES

Preparation of Neuronal Cell Cultures and Transfection-Primary
cortical neuronal cultures were established from wild-type (p53 ϩ/ϩ ) newborn pups (day 0) and from a p53 knock-out (p53 Ϫ/Ϫ ) strain (C57BL/ 6 ϫ 129 SV background) as described previously (4, 6) . Briefly, cortical brain tissue was excised, trypsinized, and dissociated by trituration to obtain single cells. Cells were then plated onto poly-D-lysine-coated cultureware (10-cm dishes for proteomics and 4-well multidish (Nunc) for all other experiments) and were maintained in Neurobasal medium with B27 supplements (Invitrogen). Under these conditions, cultures were shown to contain greater than 95% neurons, as assessed by neurofilament immunostaining (6) . Cultures were maintained for 4 days prior to experimental manipulations.
For transfection, wild-type postnatal mouse cortical neurons were co-transfected with a GFP expression vector (EGFP-N2, 0.1 g/well; BD Biosciences Clontech) and either a vector expressing a dominant negative form of protein kinase A regulatory subunit type I␣ (PKARI␣) (12) (0.4 g/well, obtained from Dr. S. McKnight) or a corresponding empty vector (for control) using LipofectAMINE 2000 (0.75 l/well; Invitrogen). Cultures were fixed 48 h later with 4% paraformaldehyde and stained with Hoechst 33258 (2.5 g/ml).
For transduction experiments, nonreplicative recombinant adenoviruses deleted in the E1 region and carrying either the human p53 gene or the AxCA lacZ ␤-galactosidase gene were prepared and used at a multiplicity of infection of 125 as described previously (4) . SH-SY5Y human neuroblastoma cells were obtained from American Type Tissue Culture Collection (Manassas, VA) and were maintained routinely in Dulbecco's modified Eagle's medium/F-12 medium with 10% fetal bovine serum. SH-SY5Y cells were plated at 1.25 ϫ 10 6 cells/60-mm dish for Western blots and were routinely plated and maintained in culture for 2 days prior to use. Approximately 24 -48 h after transduction, total cellular protein was collected and analyzed for Western blotting as described below.
ICAT Labeling of Cortical Neuron Protein Extracts-Wild-type postnatal cortical neurons that were either maintained under control conditions or exposed to the DNA damaging agent, camptothecin, were used for the mass spectrometry ICAT analyses. Neurons were scraped from four 10-cm dishes per condition in ice-cold PBS and collected by centrifugation. Cell pellets were resuspended in a minimal volume of lysis buffer containing 100 mM NH 4 HCO 3 , pH 8.3, 0.1% SDS, 1% Triton X-100, and 5 mM EDTA and sonicated in a Branson sonicator for 2 min in an ice water bath. After centrifugation at 12,000 rpm for 15 min, the supernatant was removed and stored at Ϫ80°C.
Extracted proteins from control-and camptothecin-treated wild-type cortical neurons were labeled with the light (ICAT-D 0 ) and the heavy (ICAT-D 8 ) isotopic version of the ICAT reagent (Applied Biosystems Inc., Foster City, CA), respectively, as described previously (13) . Briefly, the soluble proteins were desalted into 50 mM NH 4 HCO 3 , 5 mM EDTA, pH 8.4, and the protein concentration was measured using the Biuret assay. Guanidine HCl was added to a final concentration of 6 M. The samples were reduced by the addition of tributylphosphine (5 mM) and incubated at 37°C for 1 h. ICAT-D 0 and ICAT-D 8 were added to the control-and camptothecin-treated cortical neuron protein samples, respectively, in a 5-fold excess of the calculated approximate number of cysteine residues (assuming 1 mg of protein equals 30 nM and 6 Cys residues/protein). The reaction mixture was incubated at ambient temperature with stirring for 90 min in the dark. The two ICAT-labeled samples were combined and desalted using a 5000 molecular weight cut-off D-Salt gel filtration column (Pierce) equilibrated with 100 mM NH 4 HCO 3 , 5 mM EDTA, pH 8.4, and digested with trypsin (1:50 enzyme/protein ratio) overnight at 37°C. The digested samples were boiled for 5 min and cooled in an ice bath, and phenylmethylsulfonyl fluoride was added to a final concentration of 1 mM. A packed avidin column (1-ml bed volume) was prepared as per the manufacturer's instructions (Pierce) and equilibrated with 2ϫ PBS (pH 7.2). ICATlabeled samples were loaded onto the avidin column, which was sequentially washed with 10 column volumes each of 2ϫ PBS, 1ϫ PBS, and 20% methanol in 100 mM NH 4 HCO 3 (pH 8.4). ICAT-labeled peptides were eluted with 30% acetonitrile, 0.4% trifluoroacetic acid in water. Peptides were lyophilized to dryness and stored at Ϫ20°C.
Analysis of ICAT-labeled Peptide Samples-ICAT-labeled peptide samples were analyzed by microcapillary LC (LC) coupled on-line either with an ion trap mass spectrometer (LCQ Classic; ThermoFinnigan, San Jose, CA) or with an "in-house" built 7-tesla FTICR mass spectrometer (14) . Samples were analyzed using reversed-phase LC separations (60 cm long ϫ 150 m inner diameter ϫ 360 m outer diameter; Polymicro Technologies, Pheonix, AZ) as previously described (13) . The LC capillary was coupled to the mass spectrometers using in-house manufactured electrospray ionization interfaces with an applied electrospray ionization potential of ϳ2 kV. To identify the eluting peptides, the ion trap mass spectrometer was operated in data-dependent tandem MS mode, where the three most abundant ions detected in a precursor MS scan were dynamically selected for subsequent collisional induced dissociation (CID) in the following three tandem MS scans (IT CID energy set to 35%). Sustained off-resonance irradiation CID FTICR-MS experiments were conducted essentially as described previously (14) . The CID IT spectra were analyzed using SEQUEST, and FTICR CID spectra were searched using ICR-2LS, a software algorithm developed in-house (Pacific Northwest National Laboratory), both utilizing a data base constructed from tryptic peptides from the mouse genomic data base (www.ncbi.nih.gov).
Immunocytochemistry, Histochemistry, and Immunoblotting-Cultured neurons derived from either wild-type or p53-deficient mice were treated as described under "Results." The cells were fixed in 4% paraformaldehyde for 30 min, washed, permeabilized with 0.2% Triton X-100 in PBS for 5 min, and either immunostained as described (8) or stained with Oregon Green 488-conjugated phalloidin (Molecular Probes, Inc., Eugene, OR) to visualize F-actin according to the manufacturer's instructions. Mitotracker Red was used to stain functional mitochondria as described (15) . Neurons derived from either wild-type or p53-deficient mice were incubated with Mitotracker Red CMXRos (20 ng/ml; Molecular Probes) for 30 min and then fixed with 4% paraformaldehyde for 40 min prior to observation. Production of reactive oxygen species was visualized with the fluoroprobe 5-(and 6)-chloromethyl-2Ј,7Ј-dichlorodihydrofluorescein diacetate (CM-H 2 DCFDA; 10 M; Molecular Probes) as previously described (16) . The cultures were observed on an inverted fluorescence microscope (Zeiss Axiovert 100) designed for fluorescence imaging of living cells. Immunoblotting was performed as previously described (4) . Antibodies used were anti-protein kinase A regulatory subunit type II␣ (PKARII␣) (1:1000; Santa Cruz Biotechnology, Santa Cruz, CA), anti-PKARII␤ (1:250; BD Transduction Laboratories, San Diego, CA), anti-PKA catalytic subunit ␣ (1:1000; Santa Cruz Biotechnology), anti-MAP2 (clone AP-20, 1:400; Chemicon, Temecula, CA), anti-SOD1 (1 g/ml; Santa Cruz Biotechnology), anti-␤-actin (clone AC-15, 1:5000; Sigma), anti-HSP 60 (SPA-806; Stressgen), anti-cofilin (catalog no. 3312; Cell Signaling), anti-lamin B1 (ab8982; Abcam), anti-synaptophysin (catalog no. 902; Roche Applied Science), anti-VDAC (PA1-954; Affinity BioReagents), anti-glyceraldehyde-3-phosphate dehydrogenase (catalog no. 4300; Ambion), anti-␤-tubulin (MMS-435P; Covance Research Products), anti-Tau (MAB361; Chemicon), anti-14-3-3 (MAB3053; Chemicon), anti-histone 3 (catalog no. 9715; Cell Signaling), anti-calreticulin (SPA-600; Stressgen), and species-specific Alexa Fluor 488-or 594-conjugated secondary antibodies (1:1000; Molecular Probes).
cDNA Microarray Analysis-Total RNA was isolated from cultures of wild-type mouse cortical neurons using TRIzol reagent (Invitrogen) and the chloroform/isopropyl alcohol precipitation method. cDNA probes were prepared using reverse transcriptase (Superscript II) with oligo(dT) primer (8 M) and random 9-mers (1 g/l) (Invitrogen). The reaction mixture contained RNasin, 10 mM dithiothreitol, dNTP mix at 50 M d(AGT)TP and 10 M dCTP, and either Cy3-dCTP or Cy5-dCTP (10 M each; Amersham Biosciences) and was incubated at 42°C for 2.5 h. mRNA was subject to alkaline hydrolysis, and the probes were purified by ethanol precipitation. The labeled cDNA probes from each sample of control-and camptothecin-treated neurons were then combined and hybridized at 42°C in a humidified chamber for 14 -16 h to glass slides (Amersham Biosciences) that had been spotted with the 15K mouse unigene set (obtained from NIA, National Institutes of Health). Each expressed sequence tag was represented in duplicate on the slide set. Both Cy3-labeled and Cy5-labeled cDNA probes were prepared from each sample and used for hybridization in reversed combinations to control for artifactual biases in fluorescence intensity ratios resulting from differences inherent to the Cy3 and Cy5 dyes. Thus, essentially two separate hybridization experiments were performed, generating four data points per cDNA clone. The slides were then washed and scanned using a Molecular Dynamics GenIII scanning confocal scanner at 10-m resolution. The fluorescence ratio of Cy3/Cy5 obtained from the four separate spots for each expressed sequence tag was used to determine the relative abundance of each mRNA in the two samples. Data analysis was performed using the Spot-On computer software program developed at the University of Washington. Expression ratios of 1.4 or greater were considered significantly different.
RESULTS
ICAT mass spectrometry proteome analysis was performed using primary cortical neurons obtained from newborn (day 0) wild-type mice maintained in dissociated cell culture in a chemically defined medium for 4 days as described previously (3, 4) . DNA damage was induced by exposure to the topoisomerase I inhibitor, camptothecin (2.5 M), for 18 h. This time point was chosen to maximize differences in protein expression between control and injured neurons. At 18 h, most of the neurons were committed to undergo apoptosis, and a majority of cells showed morphological changes characteristic of programmed cell death. Control cultures exposed only to Me 2 SO vehicle showed no evidence of increased cell death under these conditions.
Crude protein extracts derived from control-or camptothecin-treated wild-type cortical neurons were prepared and separately labeled with one of two isotopically distinct versions of the ICAT reagent (ICAT-D 0 and ICAT-D 8 ). Both versions of the ICAT reagent contain a thiol-reactive group and a biotin functionality separated by a linker region, which, in the heavy version, is isotopically labeled with eight deuterium atoms in place of eight hydrogen atoms (17) . After covalent labeling, the extracts were combined and digested with trypsin, and the ICAT-modified peptides were recovered using immobilized avidin. These peptides were then separated and analyzed via LC coupled on-line with either an electrospray ionization ion trap mass spectrometer or a 7-tesla electrospray ionization Fourier transform ion cyclotron resonance mass spectrometer (electrospray ionization-FTICR-MS) (18) .
ICAT-D 0 and ICAT-D 8 peptide pairs were reproducibly separated and identified using this LC-MS approach (Fig. 1a) . Relative protein expression levels were quantitatively determined by constructing extracted ion chromatograms for each of the ICAT-labeled peptides and integrating the area under each extracted ion chromatogram for each of the D 0 /D 8 peptide pairs identified. Previous experiments in our laboratory using equivalent proteome samples or mixtures of standard proteins have suggested that ICAT measurements have an S.E. value for quantitation of 10 -25%. Based on this finding, we considered proteins whose mean abundance ratios were equal to or greater than 1.7 (increased expression when treated with camptothecin) or, alternatively, equal to or smaller than 0.3 (decreased expression when treated with camptothecin) to constitute a significant change in protein expression. However, in cases where multiple measurements from the same protein were obtained, a mean ratio of 1.4-fold or greater (increased expression when treated with camptothecin) or, alternatively, a mean ratio of 0.6-fold or less (decreased expression when treated with camptothecin) was considered significant. These peptides were identified as LQEACK from the cAMP-dependent protein kinase type II␣ regulatory subunit. One peptide species is reflected as several distinct peaks due to the naturally occurring isotopic variations of the atoms found in proteins. The quantitative change in expression of the cAMP-dependent protein kinase type II␣ regulatory domain was validated using immunostaining and Western blot analysis (see Fig. 7) . B, distribution of neuronal proteins identified by LC-MS.
Crude neuronal extracts derived from wild-type primary mouse cortical neurons were analyzed by LC-MS/MS as described under "Experimental Procedures." Approximately 150 proteins were identified using a combination of molecular weight and peptide sequence analysis. The pie chart shows the distribution of proteins after separating them into functional categories. C, correlation between changes in protein expression and changes in mRNA. This graph shows the distribution of DNA damage-induced changes in protein and mRNA levels for 48 protein/mRNA pairs. Changes of 1.4-fold or greater in protein or mRNA expression were considered significant. In ϳ33% of cases, protein levels changed despite no change in mRNA levels. Proteins were identified from nearly every intracellular compartment and organelle, and ranged in molecular mass from less than 10 kDa (cytochrome c oxidase) to greater than 210 kDa (myosin heavy chain). Both high abundance (e.g. actin and tubulin) and low abundance (e.g. cellular nucleic acid binding protein and granule cell differentiation protein) proteins were observed. As anticipated, many of the observed proteins were neuron-specific. The distribution of the identified proteins by functional class is shown in Fig. 1b. A total of 191 unique peptides corresponding to 150 proteins prepared from control-and camptothecin-treated wild-type postnatal mouse cortical neurons were identified and quantitated. The results indicated that 65% of proteins derived from camptothecin-treated neurons showed no significant change in their abundance levels. Of the remaining proteins, the abundance ratios ranged from 1.4 to cases in which the protein was only detected in either the control-or camptothecin-treated neuronal extracts. A complete list of proteins that showed a significant change in abundance is provided in Table I .
Studies have suggested that it is not always possible to predict changes in protein expression on the basis of changes in mRNA abundance (1, 17, 19) . We therefore determined DNA damage-induced changes in neuronal mRNA expression in wild-type cortical neurons using cDNA microarray analysis and compared the results to alterations in protein expression obtained using ICAT labeling in combination with LC-MS.
For the purposes of this analysis, a change of 1.4-fold or greater in mRNA expression levels was considered significant. Both mRNA and protein expression data were available for 48 proteins (Fig. 1c) . Of the 48 mRNA/protein pairs analyzed, 23 pairs (48%) displayed a change in mRNA abundance that was in the same general direction as the measured change in protein levels (including those pairs with no significant alteration in expression). Only 4 of 48 protein/mRNA pairs (8%) demonstrated no change in protein levels, despite a significant change in mRNA abundance, and there were no pairs that showed decreased protein expression levels with increased mRNA levels. However, 16 of 48 mRNA/protein pairs (33%) showed a significant change in protein expression, despite the fact that no significant change in mRNA abundance was detected. These results emphasize the importance of post-translational mechanisms in controlling cellular protein levels and demonstrate that LC-MS analysis can provide novel information about protein expression levels in mammalian systems that cannot be obtained using mRNA expression profiles alone.
Validation of ICAT Mass Spectrometry MeasurementsThe accuracy of the ICAT mass spectrometry results was confirmed using more traditional immunological techniques. Approximately 10% (14 of 150) of the proteins quantified by ICAT mass spectrometry were selected for further validation using either Western blot or immunohistochemistry analysis of cultured wild-type cortical neurons. Western blots for nine a Mean abundance ratios (D 8 /D 0 ) equal to or greater than 1.7 (increased expression) or, alternatively, equal to or smaller than 0.3 (decreased expression) represent a significant change in protein expression in the camptothecin treated wild-type neurons relative to Me 2 SO-treated wild-type control neurons. However, in cases where multiple measurements from the same protein were obtained, a mean ratio of 1.4-fold or greater (increased expression) or, alternatively, a mean ratio of 0.6-fold or less (decreased expression) was considered significant. of the proteins are shown in Fig. 2 . Immunohistochemistry and/or Western blots for an additional five proteins (␤-actin, tubulin, Tau, SOD I, and PKARII␣) are shown elsewhere in Figs. 3-7 . Immunological validation of the ICAT mass spectrometry data was performed for proteins that increased in abundance (cofilin, tubulin, VDAC1, Tau, and SOD1), decreased in abundance (PKARII␣ and lamin B1), or were unchanged (HSP60, ␤-actin, histone 3, synaptophysin, glyceraldehyde-3-phosphate dehydrogenase, 14-3-3 protein, and calreticulin) (Table II) . Densitometry was used to quantitate band intensities observed on Western blot. The results were normalized relative to actin, which was run in parallel for each protein analyzed. These quantitative Western blot data were then compared with the ICAT mass spectrometry results (see Table III ). In general, the change (or lack thereof) in protein expression measured by mass spectrometry agreed closely with the findings obtained using immunostaining or Western blot analysis. Proteins that showed changes in expression that reached significance as determined by the ICAT method also showed changes of 40% or more by Western blot, whereas those proteins that failed to show a significant change by the ICAT method showed a change of 40% or less by Western blot. These findings thus indicate that the ICAT mass spectrometry analysis of complex protein extracts described here provides valid and useful quantitative information regarding changes in neuronal protein expression.
Altered Expression of Proteins Involved in Energy Production
and Oxidative Stress-Classification of the proteins identified by LC-MS into functional groups provided an overview of diverse processes that occur simultaneously within wild-type mouse cortical neurons during p53-dependent neuronal cell death. For example, up-regulation of several proteins involved in ATP production was observed, including lactate dehydrogenase, pyruvate dehydrogenase, pyruvate kinase, and isocitrate dehydrogenase. The elevated levels of these enzymes suggested an increased dependence of the cells upon glycolysis and the tricarboxylic acid cycle, as might be predicted from a loss of mitochondrial function and declining ATP production. Indeed, previous reports have shown that p53 activation can lead to Bax translocation and mitochondrial dysfunction in embryonic neurons (11) . Using Mitotracker Red, a membrane-permeable dye that is selectively taken up by functional mitochondria, we confirmed that p53-mediated mitochondrial dysfunction occurred after DNA damage in wild-type postnatal neurons (but not p53-deficient neurons) maintained under these conditions (data not shown). Thus, both mitochondrial dysfunction and a synchronous up-regulation of enzymes involved in glycolysis and the tricarboxylic acid cycle occurred in neurons after DNA damage. This finding may help to explain the mechanism by which neuronal ATP levels are maintained, despite the decline of mitochondrial membrane potential that occurs after glutamate exposure or oxidative stress (20) .
Mass spectrometric analysis revealed increased expression of a number of antioxidative and stress response proteins (including superoxide dismutase I, peroxiredoxin I, heat shock protein 86, and arsenate resistance protein), suggesting that this might be a response to a p53-dependent increase in oxygen free radical production in neurons after DNA damage. Increased oxygen free radical production was detected after DNA damage in wild-type cortical neurons (Fig. 3) , but not in p53-deficient neurons (data not shown), after incubation in CM-H 2 DCFDA (10 M), a membrane-permeable dye that fluoresces after oxidation by reactive oxygen species (16) . Western blot analysis confirmed the mass spectrometry results indicating increased expression of SOD I in wild-type neurons after DNA damage (Fig. 3) . Taken together, these findings indicate that p53 activation in neurons not only leads to increased production of reactive oxygen species as previously described (21, 22) , but it also results in elevated expression of several antioxidative proteins.
p53-dependent Regulation of Cytoskeletal Protein Expression-A small group of proteins that have been associated with increased neurite outgrowth (rather than neurite degeneration) was found to be up-regulated after DNA damage. This result was unexpected, given the observation that widespread neurite degeneration occurs in neuronal cultures after camptothecin exposure (3, 4, 8) . Mass spectrometric analysis indicated that several isoforms of tubulin were up-regulated in wild-type neurons after DNA damage. Immunocytochemical studies confirmed that increased tubulin expression was observed as early as 8 h after camptothecin exposure (Fig. 4) , preceding morphological evidence of degeneration and apoptosis. Similarly, expression of syndecan 2 (a cell surface heparan sulfate proteoglycan that induces dendritic spine maturation (23)), CRMP-2, and CRMP-5 were increased after DNA damage (Table I) . Although phosphorylated CRMP-2 has been associated with neurite degeneration in some studies (24, 25) , enforced overexpression of CRMP-2 has been reported to induce axonogenesis in cultured hippocampal neurons (26) . Further analysis of CRMP-2 will be required to determine whether its elevated expression promotes neurite outgrowth or degeneration under these conditions.
FIG. 3. p53 activation promotes increased production of oxygen free radicals.
A-D, production of oxygen free radicals. Wild-type neurons were exposed to camptothecin or Me 2 SO (control) for 18 h and were subsequently incubated for 30 min in CM-H 2 DCFDA (10 M), a membrane-permeant dye that fluoresces after oxidation by reactive oxygen species. Whereas a low level of CM-H 2 DCFDA fluorescence was detected in control neurons (A and C), a significant increase in fluorescence intensity was detected in neurons treated with camptothecin (B and D). Phase-contrast and fluorescent images representing the same field are shown for each condition. The results are representative of three separate experiments. E, increased expression of SOD1 protein in wild-type but not p53-deficient neurons after DNA damage. Wild-type (p53 ϩ/ϩ) and p53-deficient (p53 Ϫ/Ϫ) neurons were first treated with camptothecin (2.5 M) or Me 2 SO (control) for 18 h, and protein extracts were then prepared and assessed for SOD1 protein levels by Western blot analysis (10 g of protein/lane).
Proteomic analysis also revealed altered expression of a number of proteins involved in neurite degeneration. This finding correlated with the fragmentation and dissolution of neurites observed in cultured cortical neurons treated with camptothecin (3, 4) . Plexin A1, which complexes with neuropilin-1 to form a semaphorin receptor responsible for growth cone collapse (27) , decreased by over 10-fold in wild-type neurons after DNA damage (Table I ). This complex activates LIM kinase and promotes the phosphorylation and inactivation of the actindepolymerizing protein, cofilin (28) .
Consistent with the neurite degeneration induced by camptothecin, ICAT mass spectrometry results indicated that the levels of cofilin were elevated 1.5-fold in wild-type neurons after DNA damage. This result was confirmed by Western blot analysis of wild-type neurons after DNA damage (see Fig. 2 ). Increased cofilin expression has not only been observed in the brains of Alzheimer's patients, but also in degenerating neurites of cultured hippocampal neurons after ATP depletion, oxidative stress, or excitotoxicity (29) . Moreover, enforced overexpression of the actin depolymerizing protein, ADF/cofilin, leads to intra-axonal rod formation and neurite degeneration in cultured neurons (29) . Elevated levels of dephosphorylated cofilin lead to actin depolymerization, which can be detected by a reduction in phalloidin binding (29) . In support of the ICAT LC-MS data showing increased cofilin expression after p53 activation in wild-type cortical neurons, we observed a significant decrease in phalloidin binding in wild-type neurons after camptothecin exposure that occurred prior to the onset of neurite degeneration (Fig. 5, a-d) . The decline in phalloidin binding was detected as early as 8 h after treatment (data not shown). In contrast, camptothecin exposure did not alter phalloidin binding or induce neurite degeneration in p53-deficient cortical neurons (Fig. 5, e-h ). Both LC-MS (Table II) and Western blot analysis (Fig. 5i) indicated that the reduction in phalloidin binding in wild-type neurons was not accompanied by a decline in ␤-actin levels. Actin expression was similar in wild-type and p53-deficient neurons, despite the difference in phalloidin binding observed after injury. The loss of phalloidin staining observed in the present study was consistent with a reduction in the intensity of phalloidin fluorescence in growth cones of rat cortical neurons overexpressing wild-type actin depolymerizing factor/cofilin (30) . These findings suggest that p53-dependent up-regulation of cofilin expression after DNA damage is associated with depolymerization of the actin cytoskeleton and decreased phalloidin binding in cultured primary wild-type cortical neurons. This process may contribute to the dissolution of neurites observed under these conditions.
ICAT labeling and LC-MS analysis also revealed up-regulation of the microtubule-binding protein Tau in wild-type neurons after p53 activation (Table I) . Confirmation of the ICAT result with immunohistochemistry demonstrated enhanced Tau immunoreactivity within many neurites and cell bodies, including large neuritic varicosities or swellings (Fig. 6A) .
Because the relationship between DNA damage and alterations in Tau expression has not been well characterized, we confirmed the general nature of this finding in a second neuronal model system. The addition of camptothecin to SH-SY5Y human neuroblastoma cells also produced a marked increase in Tau protein levels (Fig. 6B) . As observed for other proteins identified in this study at the 18-h time point, changes in Tau expression preceded the morphological changes that accompany neuronal apoptosis. Because camptothecin promotes p53 accumulation and activation in SH-SY5Y neuroblastoma cells 2 and neurons (11), 3 we determined whether an increase in p53 was sufficient to up-regulate Tau protein expression in these cells. Adenovirus-mediated overexpression of the human p53 gene significantly increased Tau protein expression in SH-SY5Y neuroblastoma cells relative to cells infected with lacZ alone (vector control) (Fig. 6C) , suggesting that p53 activation may contribute to the increased Tau expression and the development of cytoskeletal abnormalities associated with neurodegenerative diseases such as Alzheimer's disease. Interestingly, mass spectrometry analysis of wild-type cortical neurons indicated that one isoform of 14-3-3 (14-3-3) , which promotes the abnormal hyperphosphorylation of Tau (31), was also increased in this study after DNA damage. Four other isoforms of 14-3-3 (14-3-3 , ␤, ␥, and ) were unchanged.
p53-dependent Down-regulation of the PKA Pathway-The LC-MS results indicated that DNA damage was associated with a rapid decrease in expression of PKARII␣ in wild-type postnatal cortical neurons. Using immunocytochemistry, we confirmed that a substantial reduction in PKARII␣ expression was observed 8 h after camptothecin exposure in wild-type neurons (Fig. 7, a and b) , although decreased expression was detectable as early as 4 h after camptothecin exposure (data not shown). Further investigation revealed a decrease in expression of the PKA catalytic subunit ␣ (PKAcat) in these cells as well (Fig. 7, c and d) . Importantly, however, there were no such changes in the expression of the PKARII␤ subunit (Fig.  7, e and f) . In order to demonstrate the p53 dependence of this process in neurons, cortical neurons derived from p53-deficient mice (p53 Ϫ/Ϫ ) were exposed to camptothecin. Homozygous deletion of the p53 gene prevented the decline in the expression of the PKARII␣ (Fig. 7, g and h) and PKAcat subunits (Fig. 7, i and j) at all time points examined (4, 8, and 18 h). The LC-MS and immunostaining results for changes in PKARII␣ and PKARII␤ expression in wild-type neurons were confirmed by Western blot analysis (Fig. 7k) . Thus, DNA damage and p53 activation in neurons elicited a reduction in the expression of selected components of the PKA signaling pathway.
The significance to neuronal survival of the changes in PKA-RII␣ and PKAcat expression was demonstrated in postnatal wild-type cortical neurons using specific PKA inhibitors. Application of the cell-permeable PKA inhibitor, N-(2-[pbromocinnamylamino]ethyl)-5-isoquinolinesulfonamide (H-89), led to a decrease in neuronal survival (Fig. 8, a-f) . Wild-type mouse cortical neurons treated with as little as 20 M H89 displayed nuclear condensation (Fig. 8, e and f) and a marked reduction in MAP2 immunoreactivity (Fig. 8, c and  d) , consistent with neurite degeneration and cell death. Moreover, overexpression of a dominant negative form of PKARI␣ that inhibits cAMP-dependent protein kinase activation (12) also promoted neuronal cell death in the absence of any other cellular stress (Fig. 8, g and h) . These findings are consistent with previous reports that have implicated the PKA pathway in neuronal survival through the phosphorylation of BAD, cAMP-response element-binding protein, and other substrates (32) (33) (34) (35) (36) . DISCUSSION 
Utility of Mass Spectrometry for Neuronal Proteome Analysis-
The present study demonstrates the utility of LC-MS in combination with ICAT labeling to identify and quantitate thousands of proteins from a single extract. 4 These data also demonstrate that this method is not only useful for high throughput protein identification in the nervous system, but for protein quantification as well. We combined previously reported differential isotope labeling techniques with improved LC-MS analysis to quantitate simultaneous changes in the expression of proteins during p53-dependent neuronal cell death. It should be noted that the reproducibility of protein identifications made with the ICAT labeling technique can vary between runs. One reason for this variability is that the number of peptide molecular ions that can be selected for CID during an on-line chromatographic separation is far less than the total number of peptides in the population resulting from proteolytic digestion of a proteome sample. Tandem mass spectrometers are often configured to operate in a datadependent MS/MS fashion, where a few most abundant molecular ions observed in a precursor ion scan are sequentially isolated and subjected to CID for sequence determination. Although repeat microcapillary liquid chromatography-MS/MS analyses of complex peptide mixtures results in good overlap of peptide identifications, differences in protein abundance from experiment to experiment can prevent some proteins from being identified in every MS analysis. The ICAT labeling technique has only recently been applied to mammalian proteomes, and quantitation by this method has not previously been rigorously validated by other traditional biochemical techniques. In the present study, immunocytochemistry and Western blot analyses were used to corroborate quantitative changes in protein expression measured using LC-MS, thereby confirming the validity of the LC-MS/ICAT method. same neurodegenerative process. For example, cofilin (which was increased by DNA damage in this study) has been shown to be a major component of Hirano bodies (37, 38) , which are pathologic lesions found in Alzheimer's disease and in other neurodegenerative disorders. Proteome analysis also revealed an increase in CRMP-2 expression, which has been associated with Alzheimer's plaques in several studies (24, 25) . Similarly, increased Tau expression has been associated with neurodegenerative diseases, and Tau is a major component of the neurofibrillary tangles that are the pathologic hallmark of Alzheimer's disease. 14-3-3, a Tau-binding protein that was also increased in this study after DNA damage, is present in Alzheimer's plaques as well (39) . We also observed increases in the expression of SOD I and peroxiredoxin I during p53-dependent neuronal death. Elevated levels of both SOD I and peroxiredoxin I have been detected in the brains of Alzheimer's patients (40, 41) (A and B) and PKAcat (C and D) while showing no effect on PKAII␤ expression (E and F). Suppression of PKARII␣ and PKAcat expression was not seen in p53 Ϫ/Ϫ neurons (G-J). Note that camptothecin-induced morphological damage was not yet apparent at this time point, as revealed by nuclear staining (blue stain) with Hoechst 33258 (2.5 g/ml) and also by microscopic observation (not shown). Bar, 10 m. K, Western blotting analysis of PKARII␣ and PKARII␤ expression. Protein extracts were prepared from control-and camptothecin-treated neurons 8 h after treatment and assessed by immunoblotting (10 g of protein/lane). The blot was sequentially probed with anti-PKARII␣ and anti-PKARII␤ antibody. The findings were consistent with the immunostaining results. Each image is representative of three separate experiments.
Hallmarks of Neurodegenerative Disease Identified in Vitro by
degeneration (43) , and two-dimensional gel proteome analysis has revealed oxidative modification of UCH-L1 in brain tissue derived from patients with Alzheimer's disease (44) . The correlation of the changes in protein expression detected in this study with altered protein expression observed in neurodegenerative disease states lends further credence to the hypothesis that p53 plays a role in many of these disorders and demonstrates the power of combining differential isotope labeling with LC-MS for analysis of the neuronal proteome.
Activation of Proapoptotic and Antiapoptotic Processes during p53-dependent Death-Numerous studies have examined direct transcriptional targets of p53. However, it is apparent that both direct and downstream effects of p53 activation are relevant in determining cell survival. The overview afforded by the mass spectrometric proteome analysis used in this study revealed the novel finding that p53 activation in wild-type mouse cortical neurons results in opposing signals that can either enhance or suppress neuronal viability. Although the present findings do not allow us to conclude that p53 directly affected the expression of every protein that changed after DNA damage, we can nevertheless conclude that the presence of p53 was required for the observed changes (i.e. mitochondrial dysfunction, increased production of oxygen free radicals, altered Tau and cofilin expression, and down-regulation of the PKARII␣ regulatory subunit). These changes did not occur in neurons derived from p53-deficient mice. It seems probable that p53 orchestrates early changes in gene expression that promote cell death, whereas subsequent compensatory changes promote cell survival. The LC-MS data thus indicate that DNA damage and p53 activation initiate an opposing battle between proapoptotic and prosurvival forces in wild-type postnatal cortical neurons.
p53-dependent Suppression of Endogenous PKA Signaling Pathway-Several investigators have demonstrated that exogenous elevation of cAMP levels confers protection from numerous cellular stresses (32) (33) (34) (35) (36) . However, the present study demonstrates that cytotoxic insults can promote neuronal death by suppressing the expression of endogenous PKA signaling pathways in a p53-dependent manner. The decline in the PKA pathway observed in wild-type postnatal cortical neurons in this study required the presence of p53, and inhibition of PKA signaling promoted neuronal death. These findings thus suggest a novel mechanism by which p53 may promote cell death. It will be important to determine whether p53-mediated suppression of the PKA pathway contributes to neuronal death via the dephosphorylation of Bad and the activation of proapoptotic pathways mediated by Bax and the caspases.
While this manuscript was in preparation, several reports were published that provide evidence for a pivotal role for PKA in the regulation of Bad-mediated cell death in neurons and other tissues. Support for a critical role of PKA in controlling the activity of Bcl-2 homologues and cell death comes from work by Danial et al. (47) , who reported the presence of a mitochondrial protein complex containing PKA, Bad, glucokinase and several additional proteins. In that study, the ability of Bad to regulate mitochondrial respiration was phosphorylation dependent. Further evidence for a critical role of PKA in cell death derives from the observations of Saito et al. (48) , who reported that SOD I overexpression ameliorates neuronal cell death due to hypoxia or exogenous PKA inhibition. Several studies have indicated that neuronal death occurring after hypoxia is p53 dependent. Saito et al. presented evidence that PKA inhibition in neurons induces dephosphorylation of Bad, thereby promoting its association with Bcl-X(L) and neuronal death (as we report here). SOD1 opposes this effect by inhibiting the association of Bad with Bcl-X(L). Thus, the endogenous down-regulation of the PKA pathway observed after camptothecin exposure in the current study could contribute to cell death by promoting the association of Bad with Bcl-X(L), . An increased number of neurons showing nuclear condensation (arrowheads) were also noted in treated cultures (F), suggesting that neurons were dying by apoptosis. By 24 h after treatment, essentially all neurons were killed, and MAP2 immunoreactivity was completely lost (not shown). Hoechst staining shown in E and F represents a magnified view of the culture area outlined by white squares in the corresponding panels above. G and H, inhibition of PKA activity by dominant negative PKARI␣. Wild-type neurons were co-transfected with a GFP expression vector and a vector expressing a dominant negative form of PKARI␣ (DN-PKARI␣), which inhibits cAMP-dependent protein kinase activation (12), as described under "Experimental Procedures." Viability of GFP-positive neurons was assessed 48 h later. Neurons with degenerated neurites (arrowheads), as opposed to those with healthy neurites (arrows), were judged to be nonviable. Viability in the population of GFP-transfected cells (G) was 90 Ϯ 3.2%, which declined to 55 Ϯ 9.0% in cells co-transfected with the dominant negative form of PKARI␣ (t test; p Ͻ 0.0037) (H). 100 cells were counted per condition, and the results represent the average of three separate experiments. Comparable cell densities in the two cultures were confirmed by nuclear staining (blue). Bar, 20 m.
thereby releasing Bax to translocate to the mitochondria and activate cell death. The LC-MS analysis reported here showed that SOD I up-regulation and PKA pathway down-regulation can occur simultaneously in wild-type cortical neurons, again emphasizing the opposing nature of p53-dependent processes activated in neurons by DNA damage. Augmentation of the pro-survival processes identified here (such as SOD I up-regulation or increased expression of ATP generating enzymes) could lead to increased neuronal survival after hypoxia or after DNA damage.
